PP
BNGO icon

Paloma Partners’s Bionano Genomics BNGO Stock Holding History

Paloma Partners’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-690
Closed -$1.24M – 1796
2021
Q4 		$1.24M Buy
690
+508
+279% +$1.36M 0.02% 609
2021
Q3 		$601K Buy
182
+137
+304% +$479K 0.01% 492
2021
Q2 		$200K Sell
45
-10
-18% -$39.5K ﹤0.01% 1552
2021
Q1 		$268K Buy
+55
New +$310K 0.01% 1577

Other funds holding BNGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank Julius Baer & Co
Bank Julius Baer & Co Zurich, Switzerland $33.2B AUM 25.01% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return

Paloma Partners's BNGO Position: Q1 2022 in Review

Paloma Partners sold out of Bionano Genomics (BNGO) in Q1 2022, closing a stake of 690 shares — an estimated $1.24M sold.

Paloma Partners first reported a position in BNGO in Q1 2021 and held it in 4 quarters. The position peaked at $1.24M in Q4 2021. 148 funds tracked by Wall St. Rank hold BNGO as of Q1 2022.

  • Paloma Partners reported no remaining Bionano Genomics position as of Q1 2022 after selling out during the quarter.
  • Paloma Partners sold 690 Bionano Genomics shares in Q1 2022, an estimated $1.24M.
  • Paloma Partners first reported a position in Bionano Genomics in Q1 2021 and held it in 4 quarters.
  • Paloma Partners's Bionano Genomics position peaked at $1.24M in Q4 2021.
  • 148 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2022.

Based on Paloma Partners's 13F filing for Q1 2022, filed 16 May 2022.